Is Cardinal Health (CAH) Undervalued On Strong Earnings Expectations?

Cardinal Health (CAH) is currently considered undervalued, with a fair value of $250.53 against a share price of $236.40, driven by expectations of strong quarterly earnings and revenue. While analysts have a consensus price target aligning with this fair value, the stock's P/E ratio of 35.6x suggests richer pricing compared to the US Healthcare average, raising questions about its margin of safety if sentiment shifts. Investors are advised to consider potential risks like government pricing pressures and customer contract changes.